Adult Dosing
Steroid-responsive dermatoses
- Apply 1-2 times a day
- Notes:
- Ointment = high/medium potency; Cream, lotion = medium/low potency
- Reevaluate if no improvement after 2 wks
Pediatric Dosing
Steroid-responsive dermatoses
- Apply 1-2 times a day
- Notes:
- Ointment = high/medium potency; Cream, lotion = medium/low potency
- Reevaluate if no improvement after 2 wks
See Supplemental Patient Information
- Systemic absorption of topical corticosteroids are associated with reversible HPA axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria
- Use of more than one corticosteroid-containing product at the same time is associated with increased total systemic glucocorticoid exposure
- Do not use near eyes, or on diaper dermatitis or pre-existing skin atrophy
- Use caution if applying to face or body folds
- Periodically evaluate patients receiving a higher dose of a potent topical steroid to a large surface for evidence of HPA axis suppression by using the urinary free cortisol and ACTH stimulation tests. On presence of HPA axis suppression make an attempt to discontinue the drug, to reduce the frequency of application, or to substitute with a less potent steroid. Recovery from HPA axis function is generally prompt and complete upon withdrawal of this drug
- Children are more susceptible to systemic toxicity due to their larger skin surface to body mass ratios
- Chronic use may interfere with the growth and development of children
- On occurrence of irritation discontinue topical corticosteroids and institute appropriate therapy
- Use appropriate antifungal or antibacterial agent in the presence of dermatological infections
- On failure of occurrence of prompt favorable response discontinue corticosteroid until the infections are adequately controlled
Caution: Use cautiously in
- Pediatrics
- Skin infections
Supplemental Patient Information
- Avoid contact with the eyes
- Advise patients to consult their physician on any signs of local adverse reactions
Pregnancy Category:C
Breastfeeding: Topical betamethasone has not been evaluated during breastfeeding. Unlikely that short-term application of would pose a risk to the breastfed infant. Use the least potent drug on the smallest area of skin possible. Ensure that the infant's skin does not come into direct contact with the areas of skin that has been treated. Use lower potency corticosteroids on the nipple or areola where the infant could directly ingest the drugs from the skin. Apply only water-miscible cream or gel products to the breast because ointments may expose the infant to high levels of mineral paraffins via licking. Wiped off any topical corticosteroid prior to nursing if it is applied to the breast or nipple area. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 19 February 2011). Manufacturer advises caution.
US Trade Name(s)
- Beta-Val
- Dermabet
- Luxiq
- Valnac
US Availability
betamethasone valerate (generic)
- CRE: 0.1%
- OINT: 0.1%
- LOTN: 0.1%
- FOAM: 0.12%
Beta-Val
Dermabet
Luxiq
Valnac
Canadian Trade Name(s)
- Betaderm
- Prevex B
- Ratio-Ectosone
- Ratio-Ectosone
- Rivasone
- Valisone
Canadian Availability
Betaderm
- CRE: 0.05%
- CRE: 0.1%
- OINT: 0.05%
- OINT: 0.1%
- LOTN: 0.1%
Prevex B
Ratio-Ectosone
- CRE: 0.05%
- CRE: 0.1%
- LOTN: 0.05%
- LOTN: 0.1%
Ratio-Ectosone, Rivasone, Valisone
UK Trade Name(s)
- Betacap
- Betnovate
- Betnovate-RD
- Bettamousse
- Diprosone
UK Availability
betamethasone valerate (generic)
Betacap
Betnovate
- CRE: 0.1%
- OINT: 0.1%
- LOTN: 0.1%
- Scalp SOLN: 0.1%
Betnovate-RD
Bettamousse
Diprosone
- CRE: 0.05%
- OINT: 0.05%
- LOTN: 0.05%
Australian Trade Name(s)
- Antroquoril
- Betnovate
- Celestone M
- Cortival
Australian Availability
Antroquoril
Betnovate
- CRE: 0.02%
- CRE: 0.05%
- CRE: 0.1%
- OINT: 0.1%
- OINT: 0.05%
Celestone M
Cortival
- CRE: 0.02%
- CRE: 0.05%
- OINT: 0.05%
Pricing data from www.DrugStore.com in U.S.A.
- Luxiq 0.12 % FOAM [Can] (GLAXO SMITH KLINE)
50 % = $177.99
150 % = $512.97 - Betamethasone Valerate 0.1 % LOTN [Bottle] (FOUGERA)
60 % = $57.99
120 % = $103.97 - Beta-Val 0.1 % CREA [Tube] (TEVA PHARMACEUTICALS USA)
45 % = $12.99
135 % = $25.98 - Betamethasone Valerate 0.1 % CREA [Tube] (FOUGERA)
15 % = $22.99
30 % = $35.97 - Betamethasone Valerate 0.1 % CREA [Tube] (FOUGERA)
45 % = $39.99
90 % = $64.97 - Beta-Val 0.1 % CREA [Tube] (TEVA PHARMACEUTICALS USA)
15 % = $11.99
45 % = $15.97 - Betamethasone Valerate 0.1 % OINT [Tube] (FOUGERA)
15 % = $25.99
45 % = $59.97 - Luxiq 0.12 % FOAM [Can] (GLAXO SMITH KLINE)
100 % = $319.99
300 % = $939.97 - Betamethasone Valerate 0.1 % OINT [Tube] (FOUGERA)
45 % = $40.99
135 % = $103.99
Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.